Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial (Q38820633)

6 September 2017

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial (English)

1 reference

multicenter clinical trial

6 September 2017

0 references

0 references

1 reference

Jan Bolinder

1

1 reference

6 September 2017

Ramiro Antuna

2

1 reference

6 September 2017

Petronella Geelhoed-Duijvestijn

3

1 reference

6 September 2017

Jens Kröger

4

1 reference

6 September 2017

Raimund Weitgasser

5

1 reference

6 September 2017

language of work or name

English

0 references

publication date

9 September 2016

1 reference

6 September 2017

1 reference

6 September 2017

388

1 reference

6 September 2017

10057

1 reference

6 September 2017

2254-2263

1 reference

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Hypoglycaemia: current management and controversies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Diverse causes of hypoglycemia-associated autonomic failure in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Assessing psychosocial distress in diabetes: development of the diabetes distress scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

The effect of continuous glucose monitoring in well-controlled type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Evaluation of a new measure of blood glucose variability in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2931535-5

7 January 2021

10.1016/S0140-6736(16)31535-5

Identifiers

DOI

1 reference

6 September 2017

1 reference